In vitro proliferative activity of 6-substituted uracil derivatives

Context: Previously, we investigated the relationship between the nature of the substituent at the 5-position of the uracil ring and the action of the corresponding uracil derivatives on immortalized lung cells. In the present study, we analyzed the impact of some 6-substituted uracil-derivatives on...

Full description

Bibliographic Details
Main Authors: Stanislav A. Grabovskiy, Natalia N. Kabal’nova, Nadezhda M. Andriayshina, Vladislav I. Egorov, Lenar R. Valiullin, Alexey A. Nabatov, Ivan S. Raginov, Yurii I. Murinov
Format: Article
Language:English
Published: Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) 2021-05-01
Series:Journal of Pharmacy & Pharmacognosy Research
Subjects:
Online Access:https://jppres.com/jppres/pdf/vol9/jppres20.944_9.3.357.pdf
Description
Summary:Context: Previously, we investigated the relationship between the nature of the substituent at the 5-position of the uracil ring and the action of the corresponding uracil derivatives on immortalized lung cells. In the present study, we analyzed the impact of some 6-substituted uracil-derivatives on the regeneration potential of the lung cells (LC). Aims: To evaluate uracil derivatives capable of stimulating lung cell proliferation to create drugs that accelerate lung regeneration. Methods: The level of cell proliferation, maximum tolerated dose, and toxic effect of 6-substituted uracil derivatives (9 compounds) were studied on the immortalized lung epithelial cells and compared with the known drug 6-methyluracil. Results: The maximum tolerated dose of compounds for the LC line depends on the chemical structure of the compounds. The highest level of cell proliferation and tolerated was demonstrated when was used 3-methyl-6-cyclopropyluracil and 1-butyl-6-methyluracil. Conclusions: 3-methyl-6-cyclopropyluracil and 1-butyl-6-methyluracil exhibit a high proliferative activity in vitro so they could be recommended for additional studies of regenerative activity in vivo.
ISSN:0719-4250